Go Beyond the Headlines.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Cannes Film Festival
Social Media
Donald Trump
Artificial Intelligence
US Politics
Republican Party
Democratic Party
Taxes
Baseball
Senate
Soccer
Boxing
Published • loading... • Updated

Genespire Presents Promising Preclinical Data on Liver-Directed Gene Therapy for MMA at ASGCT 2025

Summary by GeneOnline News
Genespire presented preclinical dosing data for its liver-directed gene therapy for MMA at ASGCT 2025, targeting pediatric genetic diseases.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
GeneOnline NewsGeneOnline News

Genespire Presents Promising Preclinical Data on Liver-Directed Gene Therapy for MMA at ASGCT 2025

Genespire presented preclinical dosing data for its liver-directed gene therapy for MMA at ASGCT 2025, targeting pediatric genetic diseases.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GeneOnline News broke the news in on Wednesday, May 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal